# EDGAR Filing Document

**Accession Number:** 0001388111
**File Stem:** 0000899243-23-007222
**Filing Date:** 2023-3
**Character Count:** 11166
**Document Hash:** 9540c0b72c78866ee0424a319414e13f
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000899243-23-007222.hdr.sgml**: 20230306

**ACCESSION NUMBER**: 0000899243-23-007222

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20230302

**FILED AS OF DATE**: 20230306

**DATE AS OF CHANGE**: 20230306

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Malik Rajiv
- **CENTRAL INDEX KEY:** 0001388111

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-39695
- **FILM NUMBER:** 23710533

**MAIL ADDRESS:**
- **STREET 1:** BUILDING 4, TRIDENT PLACE
- **STREET 2:** MOSQUITO WAY
- **CITY:** HATFIELD, HERTFORDSHIRE
- **STATE:** X0
- **ZIP:** AL10 9UL
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Viatris Inc
- **CENTRAL INDEX KEY:** 0001792044
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **IRS NUMBER:** 834364296
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 1000 MYLAN BOULEVARD
- **CITY:** CANONSBURG
- **STATE:** PA
- **ZIP:** 15317
- **BUSINESS PHONE:** (724) 514-1465

**MAIL ADDRESS:**
- **STREET 1:** 1000 MYLAN BOULEVARD
- **CITY:** CANONSBURG
- **STATE:** PA
- **ZIP:** 15317

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Upjohn Inc
- **DATE OF NAME CHANGE:** 20191023

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[ ] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Malik Rajiv<br><sub>(Last) (First) (Middle)</sub><br>1000 MYLAN BOULEVARD<br><sub>(Street)</sub><br>CANONSBURG, PA 15317<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2023-03-02 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[X] Director [ ] 10% Owner<br>[X] Officer (give title below) [ ] Other (specify below)<br>_President_ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>Viatris Inc [ VTRS ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Common Stock | 2023-03-02 |  | M |  | 52632 | A | $0.00 | 473628 | D |  |
| Common Stock | 2023-03-02 |  | F |  | 22874<sup>(1)</sup> | D | $11.13 | 450754 | D |  |
| Common Stock | 2023-03-02 |  | M |  | 197369 | A | $0.00 | 648123 | D |  |
| Common Stock | 2023-03-02 |  | F |  | 85817<sup>(2)</sup> | D | $11.13 | 562306 | D |  |
| Common Stock | 2023-03-02 |  | M |  | 67180 | A | $0.00 | 629486 | D |  |
| Common Stock | 2023-03-02 |  | F |  | 29210<sup>(3)</sup> | D | $11.13 | 600276 | D |  |
| Common Stock | 2023-03-02 |  | M |  | 5313<sup>(4)</sup> | A | $0.00 | 605589 | D |  |
| Common Stock | 2023-03-02 |  | F |  | 2311<sup>(5)</sup> | D | $11.13 | 603278 | D |  |
| Common Stock | 2023-03-04 |  | M |  | 82353 | A | $0.00 | 685631 | D |  |
| Common Stock | 2023-03-04 |  | F |  | 35808<sup>(6)</sup> | D | $11.13 | 649823 | D |  |
| Common Stock | 2023-03-04 |  | M |  | 2961<sup>(7)</sup> | A | $0.00 | 652784 | D |  |
| Common Stock | 2023-03-04 |  | F |  | 1288<sup>(8)</sup> | D | $11.13 | 651496 | D |  |
| Common Stock |  |  |  |  |  |  |  | 460319 | I | By Irrevocable Trust |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| Restricted Stock Units | $0.00 | 2023-03-02 |  | M |  |  | 52632 | <sup>(9)</sup> | <sup>(9)</sup> | Common Stock | 52632 | $0.00 | 0 | D |  |
| Restricted Stock Units | $0.00 | 2023-03-02 |  | M |  |  | 197369 | <sup>(10)</sup> | <sup>(10)</sup> | Common Stock | 197369 | $0.00 | 0 | D |  |
| Restricted Stock Units | $0.00 | 2023-03-02 |  | M |  |  | 67180 | <sup>(11)</sup> | <sup>(11)</sup> | Common Stock | 67180 | $0.00 | 67180 | D |  |
| Dividend Equivalent Units | $0.00 | 2023-03-02 |  | M |  |  | 5312.2276<sup>(12)</sup> | <sup>(13)</sup> | <sup>(13)</sup> | Common Stock | 5312.2276 | $0.00 | 5313<sup>(12)</sup> | D |  |
| Restricted Stock Units | $0.00 | 2023-03-03 |  | A |  | 245284 |  | <sup>(14)</sup> | <sup>(14)</sup> | Common Stock | 245284 | $0.00 | 245284 | D |  |
| Restricted Stock Units | $0.00 | 2023-03-04 |  | M |  |  | 82353 | <sup>(15)</sup> | <sup>(15)</sup> | Common Stock | 82353 | $0.00 | 164706 | D |  |
| Dividend Equivalent Units | $0.00 | 2023-03-04 |  | M |  |  | 2960.9403<sup>(16)</sup> | <sup>(17)</sup> | <sup>(17)</sup> | Common Stock | 2960.9403 | $0.00 | 5920<sup>(16)</sup> | D |  |

---

### Footnotes:

(1) Represents withholding of shares of common stock for the tax liability associated with the vesting and settlement of a portion of the restricted stock units (RSUs) granted on March 2, 2020.

(2) Represents withholding of shares of common stock for the tax liability associated with the vesting and settlement of the RSUs granted on March 2, 2020.

(3) Represents withholding of shares of common stock for the tax liability associated with the vesting and settlement of a portion of the RSUs granted on March 2, 2021.

(4) Fractional shares have been rounded up in connection with the settlement described in footnote 13 pursuant to the terms of the RSU award agreement under the Viatris Inc. 2020 Stock Incentive Plan.

(5) Represents withholding of shares of common stock for the tax liability associated with the vesting and settlement of a portion of the dividend equivalent units (DEUs) that accrued with respect to the RSUs previously granted on March 2, 2021.

(6) Represents withholding of shares of common stock for the tax liability associated with the vesting and settlement of a portion of the RSUs granted on March 4, 2022.

(7) Fractional shares have been rounded up in connection with the settlement described in footnote 17 pursuant to the terms of the RSU award agreement under the Viatris Inc. 2020 Stock Incentive Plan.

(8) Represents withholding of shares of common stock for the tax liability associated with the vesting and settlement of a portion of the DEUs that accrued with respect to the RSUs previously granted on March 4, 2022.

(9) Each RSU represents the right to receive one share of common stock of Viatris Inc. (Viatris).  52,632 of the RSUs granted on March 2, 2020 vested on March 2, 2021, 52,631 vested on March 2, 2022 and 52,632 vested on March 2, 2023.

(10) Each RSU represents the right to receive one share of common stock of Viatris.  These RSUs vested in full on March 2, 2023.

(11) Each RSU represents the right to receive one share of common stock of Viatris.  67,180 of the RSUs granted on March 2, 2021 vested on each of March 2, 2022 and March 2, 2023 and 67,180 will vest on March 2, 2024.

(12) On May 6, 2022, Viatris filed a registration statement on Form S-3 with respect to its Dividend Reinvestment and Share Purchase Plan; amount includes DEUs that subsequently accrued with respect to such RSUs in June 2022, September 2022 and December 2022 in transactions exempt from Section 16 under Rule 16a-11.

(13) Represents DEUs that accrued with respect to the RSUs previously granted on March 2, 2021 and vest on the same schedule as the underlying RSUs.

(14) Each RSU represents the right to receive one share of common stock of Viatris. 81,762 of the RSUs granted on March 3, 2023 will vest on March 3, 2024 and 81,761 will vest on each of March 3, 2025 and March 3, 2026.

(15) Each RSU represents the right to receive one share of common stock of Viatris.  82,353 of the RSUs granted on March 4, 2022 vested on March 4, 2023 and 82,353 will vest on each of March 4, 2024 and March 4, 2025.

(16) On May 6, 2022, Viatris filed a registration statement on Form S-3 with respect to its Dividend Reinvestment and Share Purchase Plan; amount represents DEUs that subsequently accrued with respect to such RSUs in June 2022, September 2022 and December 2022 in transactions exempt from Section 16 under Rule 16a-11.

(17) Represents DEUs that accrued with respect to the RSUs previously granted on March 4, 2022 and vest on the same schedule as the underlying RSUs.

**Signature:** /s/ Kevin Macikowski, by power of attorney  
**Date:** 2023-03-06

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**